Data search


search
Exact
Search

Results for MligTC455_15005

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_15005 13 0.26 Mlig455_007503

Neo: -

Age: -

Mlig455_007503 {REF} {Length: 2488} {Pfam: Immunoglobulin domain [PF13895.8, score=20.5]} {RNA1310_66411} {RNA815_43821}

Cumulative graph for MligTC455_15005

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 0.669 0.624 1.00000 1.00000
RegionR2 -0.171 0.624 0.99984 1.00000
RegionR3 -0.231 0.624 1.00000 1.00000
RegionR4 -0.092 0.624 0.99984 1.00000
RegionR5 -0.308 0.624 1.00000 1.00000
RegionR6 -0.325 0.624 0.99980 1.00000
RegionR7 0.095 0.624 0.99994 1.00000
RegionR8 0.362 0.624 0.99986 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -0.573 0.624 1.00000 1.00000
RegenerationR2 2.857 0.624 0.25634 0.70273
RegenerationR3 2.616 0.624 0.70015 0.94763
RegenerationR4 -0.309 0.624 1.00000 1.00000
RegenerationR5 1.865 0.624 0.60860 0.91378
RegenerationR6 2.911 0.624 0.55683 0.84324
RegenerationBL -0.304 0.624 1.00000 1.00000
RegenerationTP -0.336 0.624 0.99983 1.00000


Genes with expression patterns similar to MligTC455_15005

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_15005 13 0.26 Mlig455_007503

Neo: -

Age: -

1 - - - - 1.000 - Mlig455_007503 {REF} {Length: 2488} {Pfam: Immunoglobulin domain [PF13895.8, score=20.5]} {RNA1310_66411} {RNA815_43821}
2. MligTC455_42103 19 0.4 Mlig455_013890

Neo: -

Age: -

ARID3A 0.997 - - - - 0.997 - Mlig455_013890 {REF} {Length: 2772} {Pfam: ARID/BRIGHT DNA binding domain [PF01388.23, score=72.2]} {Human: ENSG00000116017, ARID3A, AT-rich interaction domain 3A, [RH, Score=244, Expect=2e-71]; ENSG00000205143, ARID3C, AT-rich interaction domain 3C, [RH, Score=242, Expect=1e-72]; ENSG00000179361, ARID3B, AT-rich interaction domain 3B, [RH, Score=233, Expect=8e-68]} {Mouse: ENSMUSG00000019564, Arid3a, AT rich interactive domain 3A (BRIGHT-like), [RH, Score=247, Expect=9e-73]; ENSMUSG00000066224, Arid3c, AT rich interactive domain 3C (BRIGHT-like), [RH, Score=245, Expect=2e-74]} {Dmel: FBgn0004795, retn, retained, [RH, Score=241, Expect=2e-68]} {Celegans: WBGene00000476, cfi-1, AT-rich interactive domain-containing protein cfi-1, [RH, Score=231, Expect=3e-68]} {Smed: dd_Smed_v6_13474_0_1, dd_Smed_v6_13474_0_1, [RH, Score=259, Expect=1e-77]} {RNA1509_54880} {RNA1310_44805} {RNA815_49768}
3. MligTC455_31210 51 1.07 Mlig455_028581

Neo: -

Age: Down-Up-Down

KCNH7 0.995 - - - - 0.995 - Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478}
4. MligTC455_49214 6 0.13 Mlig455_068565

Neo: -

Age: -

0.995 - - - - 0.995 - Mlig455_068565 {REF} {Length: 1544} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=105.5]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=53.1, Expect=3e-08]} {RNA1310_27155} {RNA815_39321}
5. MligTC455_14124 9 0.19 Mlig455_004227, Mlig455_031052, Mlig455_031059

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-1.177

OTOGL, SSPO 0.993 - - - - 0.993 -

Mlig455_004227 {REF} {Length: 8347} {Pfam: von Willebrand factor type D domain [PF00094.27, score=218.9]; C8 domain [PF08742.13, score=94.5]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.7]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=52.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=506, Expect=2e-143]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=499, Expect=2e-141]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=5e-89]} {Celegans: WBGene00020481, T13C2.6, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1126, Expect=0.0]} {RNA1509_11979, RNA1509_44751} {RNA1310_598, RNA1509_44751} {RNA1509_44751, RNA815_582}

Mlig455_031052 {REF} {Length: 3393} {Pfam: von Willebrand factor type D domain [PF00094.27, score=117.0]; C8 domain [PF08742.13, score=60.4]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.8]} {Human: ENSG00000165899, OTOGL, otogelin like, [Score=200, Expect=1e-51]} {Mouse: ENSMUSG00000001930, Vwf, Von Willebrand factor, [Score=200, Expect=8e-52]; ENSMUSG00000091455, Otogl, otogelin-like, [Score=196, Expect=1e-50]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=149, Expect=4e-36]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=497, Expect=7e-154]} {RNA1509_47011} {RNA1310_598} {RNA815_582}

Mlig455_031059 {REF} {Length: 5292} {Pfam: von Willebrand factor type D domain [PF00094.27, score=221.4]; C8 domain [PF08742.13, score=99.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=52.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=489, Expect=4e-142]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=488, Expect=6e-142]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=322, Expect=1e-88]} {Celegans: WBGene00003071, lrp-1, Low-density lipoprotein receptor-related protein, [Score=74.7, Expect=6e-13]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1061, Expect=0.0]} {RNA1509_47011} {RNA1310_598} {RNA815_582}
6. MligTC455_05979 11 0.23 Mlig455_067718

Neo: -

Age: -

0.986 - - - - 0.986 - Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367}
7. MligTC455_10204 14 0.29 Mlig455_049702, Mlig455_049708

Neo: -

Age: -

0.986 - - - - 0.986 -

Mlig455_049702 {REF} {Length: 217} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_47324} {RNA815_43123}

Mlig455_049708 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_57782} {RNA815_43123}
8. MligTC455_33637 187 3.9 Mlig455_027211, Mlig455_027458

Neo: -

Age: -

Region-enriched R2: 3.458/0.04514

CHRNA10, CHRNA7 0.981 - - - - 0.981 -

Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2}

Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2}
9. MligTC455_11494 99 2.06 Mlig455_055605

Neo: -

Age: Down-Up-Down

HS3ST5 0.979 - - - - 0.979 - Mlig455_055605 {REF} {Length: 2196} {Pfam: Sulfotransferase domain [PF00685.29, score=91.7]; Sulfotransferase family [PF13469.8, score=45.8]} {Human: ENSG00000249853, HS3ST5, heparan sulfate-glucosamine 3-sulfotransferase 5, [RH, Score=256, Expect=1e-82]} {Mouse: ENSMUSG00000044499, Hs3st5, heparan sulfate (glucosamine) 3-O-sulfotransferase 5, [RH, Score=257, Expect=2e-83]} {Dmel: FBgn0031005, Hs3st-B, Heparan sulfate 3-O sulfotransferase-B, [Score=205, Expect=9e-63]} {Celegans: WBGene00044303, hst-3.2, Heparan SulphoTransferase, [Score=215, Expect=7e-68]} {Smed: dd_Smed_v6_81402_0_1, dd_Smed_v6_81402_0_1, [Score=123, Expect=7e-34]} {RNA1310_37118} {RNA815_58609}
10. MligTC455_00655 14 0.29 Mlig455_065816

Neo: -

Age: -

0.974 - - - - 0.974 - Mlig455_065816 {REF} {Length: 2762} {RNA1310_102038}
11. MligTC455_24787 87 1.82 Mlig455_065253

Neo: -

Age: -

0.973 - - - - 0.973 - Mlig455_065253 {REF} {Length: 1051} {TRANSSPLICED} {RNA1509_24218} {RNA1310_25312.2} {RNA815_14520}
12. MligTC455_26816 355 7.39 Mlig455_062861

Neo: -

Age: logFC(26M/2M)=-0.333

TTLL10 0.973 - - - - 0.973 - Mlig455_062861 {REF} {Length: 4729} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=173.8]; YheC/D like ATP-grasp [PF14398.8, score=30.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=27.4]; Sugar-transfer associated ATP-grasp [PF14397.8, score=20.6]} {Human: ENSG00000162571, TTLL10, tubulin tyrosine ligase like 10, [RH, Score=323, Expect=5e-100]} {Mouse: ENSMUSG00000029074, Ttll10, tubulin tyrosine ligase-like family, member 10, [RH, Score=319, Expect=2e-98]} {Dmel: FBgn0030823, CG8918, [Score=129, Expect=2e-31]} {Celegans: WBGene00044187, ttll-9, Tubulin Tyrosine Ligase Like, [Score=99.4, Expect=5e-22]} {Smed: dd_Smed_v6_9664_0_1, dd_Smed_v6_9664_0_1, [RH, Score=445, Expect=2e-147]} {RNA1509_23478, RNA1509_31433, RNA1509_39757} {RNA1310_12709.1, RNA1509_23478, RNA1509_31433, RNA1509_39757} {RNA1509_23478, RNA1509_31433, RNA1509_39757, RNA815_2937}
13. MligTC455_00715 24 0.51 Mlig455_060639

Neo: -

Age: -

0.969 - - - - 0.969 - Mlig455_060639 {REF} {Length: 802} {NoTransDecoderORF} {RNA1509_54585} {RNA1310_91888} {RNA815_7856.1}
14. MligTC455_26817 353 7.36 Mlig455_062943

Neo: -

Age: logFC(26M/2M)=-0.515

TTLL10 0.968 - - - - 0.968 - Mlig455_062943 {REF} {Length: 3909} {Pfam: Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=21.8]} {Human: ENSG00000162571, TTLL10, tubulin tyrosine ligase like 10, [Score=69.7, Expect=2e-12]} {Mouse: ENSMUSG00000029074, Ttll10, tubulin tyrosine ligase-like family, member 10, [Score=58.2, Expect=8e-09]} {Smed: dd_Smed_v6_9664_0_1, dd_Smed_v6_9664_0_1, [Score=87.4, Expect=9e-19]} {RNA1509_23478} {RNA1310_12709.1} {RNA815_2937}
15. MligTC455_24515 14 0.28 Mlig455_033346, Mlig455_033365

Neo: -

Age: -

HTR1B 0.966 - - - - 0.966 -

Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724}

Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724}
16. MligTC455_31212 97 2.02 Mlig455_028599, Mlig455_056911

Neo: -

Age: -

0.966 - - - - 0.966 -

Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362}

Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362}
17. MligTC455_19888 22 0.46 Mlig455_066525

Neo: -

Age: -

AC254952.1 0.964 - - - - 0.964 - Mlig455_066525 {REF} {Length: 1890} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=188.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=20.4]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=188, Expect=5e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=185, Expect=4e-56]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=195, Expect=4e-58]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=242, Expect=1e-75]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=175, Expect=7e-51]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=228, Expect=9e-71]} {RNA1310_34222.1} {RNA815_33884}
18. MligTC455_22853 33 0.7 Mlig455_019405, Mlig455_059068

Neo: -

Age: -

0.964 - - - - 0.964 -

Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811}

Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811}
19. MligTC455_35325 26 0.54 Mlig455_008452, Mlig455_031353, Mlig455_056519

Neo: -

Age: -

HTR3A 0.964 - - - - 0.964 -

Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010}

Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010}

Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010}
20. MligTC455_13028 20 0.41 Mlig455_004716

Neo: -

Age: -

0.963 - - - - 0.963 - Mlig455_004716 {REF} {Length: 656} {NoTransDecoderORF}
21. MligTC455_01796 16 0.32 Mlig455_044192

Neo: -

Age: -

0.962 - - - - 0.962 - Mlig455_044192 {REF} {Length: 437} {NoTransDecoderORF} {RNA1509_18603} {RNA1310_53435} {RNA815_26807}
22. MligTC455_27521 681 14.19 Mlig455_050046

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=0.667

Region-enriched R2: 1.375/0.04610

ABCG2 0.962 - - - - 0.962 - Mlig455_050046 {REF} {Length: 3109} {Pfam: ABC-2 type transporter [PF01061.26, score=96.6]; ABC transporter [PF00005.29, score=96.0]; ABC-2 type transporter [PF19055.2, score=48.9]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=25.0]} {Human: ENSG00000118777, ABCG2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=248, Expect=2e-72]} {Mouse: ENSMUSG00000029802, Abcg2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=249, Expect=4e-73]} {Dmel: FBgn0020445, E23, Early gene at 23, [RH, Score=389, Expect=3e-122]} {Celegans: WBGene00015479, wht-1, ABC transporter ATP-binding protein/permease wht-1, [Score=220, Expect=4e-63]} {Smed: dd_Smed_v6_4081_0_1, dd_Smed_v6_4081_0_1, [RH, Score=222, Expect=4e-63]} {RNA1509_19841, RNA1509_37967, RNA1509_52359} {RNA1310_6299.1, RNA1509_37967, RNA1509_52359} {RNA1509_37967, RNA1509_52359, RNA815_1994.1}
23. MligTC455_24162 48 1 Mlig455_014024

Neo: -

Age: -

0.961 - - - - 0.961 - Mlig455_014024 {REF} {Length: 3118} {RNA1310_27501} {RNA815_14263}
24. MligTC455_26562 51 1.05 Mlig455_003821

Neo: -

Age: -

Region-enriched R4: 4.788/0.04787

0.961 - - - - 0.961 - Mlig455_003821 {REF} {Length: 3329} {NoTransDecoderORF} {RNA1509_310} {RNA1310_3669} {RNA815_20255}
25. MligTC455_39100 62 1.29 Mlig455_009476

Neo: -

Age: Down-Up-Down

Region-enriched R4: 3.504/0.03677

CABP7 0.961 - - - - 0.961 - Mlig455_009476 {REF} {Length: 960} {Pfam: EF hand [PF00036.34, score=45.6]; EF-hand domain [PF13405.8, score=35.6]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF hand [PF13202.8, score=28.1]} {Human: ENSG00000100314, CABP7, calcium binding protein 7, [Score=46.6, Expect=1e-05]} {Mouse: ENSMUSG00000009075, Cabp7, calcium binding protein 7, [Score=46.6, Expect=8e-06]} {Celegans: WBGene00015264, B0563.7, Uncharacterized calcium-binding protein B0563.7, [Score=50.4, Expect=3e-07]} {Smed: dd_Smed_v6_13677_0_1, dd_Smed_v6_13677_0_1, [RH, Score=185, Expect=1e-57]} {RNA1509_25282} {RNA1310_29885.1} {RNA815_14774.1}
26. MligTC455_39988 83 1.73 Mlig455_062081

Neo: -

Age: -

0.96 - - - - 0.960 - Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4}
27. MligTC455_50029 35 0.74 Mlig455_010619, Mlig455_010708

Neo: -

Age: -

FOXA1 0.96 - - - - 0.960 -

Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]}

Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]}
28. MligTC455_52421 10 0.21 Mlig455_003617

Neo: -

Age: -

0.96 - - - - 0.960 - Mlig455_003617 {REF} {Length: 1233} {RNA1509_48973} {RNA1310_67118.1} {RNA815_36286}
29. MligTC455_20379 17 0.36 Mlig455_013410

Neo: -

Age: -

Region-enriched R2: 6.911/0.01361

PLSCR2 0.959 - - - - 0.959 - Mlig455_013410 {REF} {Length: 1971} {Pfam: Scramblase [PF03803.17, score=92.3]} {Human: ENSG00000163746, PLSCR2, phospholipid scramblase 2, [Score=77.8, Expect=2e-15]; ENSG00000114698, PLSCR4, phospholipid scramblase 4, [Score=77.0, Expect=5e-15]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=84.3, Expect=1e-17]} {Celegans: WBGene00011935, scrm-1, Phospholipid scramblase, [Score=89.7, Expect=6e-20]} {RNA1310_32034} {RNA815_51815}
30. MligTC455_14578 33 0.69 Mlig455_033066

Neo: -

Age: -

0.958 - - - - 0.958 - Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177}
31. MligTC455_27522 684 14.26 Mlig455_050093

Neo: -

Age: logFC(26M/2M)=5.091

0.958 - - - - 0.958 - Mlig455_050093 {REF} {Length: 1057} {NoTransDecoderORF} {RNA1509_37967} {RNA1310_6299.1} {RNA815_1994.1}
32. MligTC455_25410 47 0.97 Mlig455_026185

Neo: -

Age: Up-Down-Down

Region-enriched R2: 8.036/0.00469
Region-enriched R6: 6.422/0.01487

0.956 - - - - 0.956 - Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868}
33. MligTC455_23922 8 0.17 Mlig455_001765

Neo: -

Age: Down-Up-Down

0.954 - - - - 0.954 - Mlig455_001765 {REF} {Length: 4721} {Pfam: AMP-binding enzyme [PF00501.30, score=68.9]} {RNA1509_37800} {RNA1310_40483} {RNA815_30709}
34. MligTC455_34791 363 7.55 Mlig455_023393

Neo: -

Age: Down-Up-Up

0.954 - - - - 0.954 - Mlig455_023393 {REF} {Length: 2051} {Smed: dd_Smed_v6_27312_0_1, dd_Smed_v6_27312_0_1, [Score=95.5, Expect=2e-20]} {RNA1509_6675} {RNA1310_2307} {RNA815_650}
35. MligTC455_20178 15 0.31 Mlig455_053660

Neo: -

Age: -

0.953 - - - - 0.953 - Mlig455_053660 {REF} {Length: 922} {Pfam: LegC3 N-terminal coiled-coil domain [PF18654.3, score=18.5]} {RNA1310_88410}
36. MligTC455_40204 348 7.24 Mlig455_064913, Mlig455_066843

Neo: -

Age: logFC(26M/2M)=-0.350

0.953 - - - - 0.953 -

Mlig455_064913 {REF} {Length: 1143} {NoTransDecoderORF} {RNA1509_52747} {RNA1310_89294} {RNA815_41786}

Mlig455_066843 {REF} {Length: 633} {NoTransDecoderORF} {RNA1310_106751} {RNA815_41786}
37. MligTC455_29153 62 1.28 Mlig455_018743, Mlig455_018911

Neo: -

Age: -

0.951 - - - - 0.951 -

Mlig455_018743 {REF} {Length: 1064} {RNA1509_38365} {RNA1310_117516} {RNA815_19813}

Mlig455_018911 {REF} {Length: 2829} {RNA1509_38365} {RNA1310_117516} {RNA815_28950}
38. MligTC455_40947 334 6.97 Mlig455_035957

Neo: -

Age: Up-Down-Down

FSIP1 0.95 - - - - 0.950 - Mlig455_035957 {REF} {Length: 3167} {TRANSSPLICED} {Pfam: FSIP1 family [PF15554.8, score=178.4]} {Human: ENSG00000150667, FSIP1, fibrous sheath interacting protein 1, [RH, Score=108, Expect=5e-24]} {Mouse: ENSMUSG00000027344, Fsip1, fibrous sheath-interacting protein 1, [RH, Score=101, Expect=4e-22]} {Smed: dd_Smed_v6_16017_0_1, dd_Smed_v6_16017_0_1, [RH, Score=119, Expect=2e-28]} {RNA1509_20339} {RNA1310_6204.1} {RNA815_13781}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA